INVESTOR ALERT: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Bionics (BBNX) Ready to Announce with Confidence?
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses Beta Bionics Stock or Options To Contact Him Directly At 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - March 20, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: BBNX).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
On January 9, 2026, shares of Beta Bionics declined sharply in trading, following the company's disclosure of preliminary fourth-quarter 2025 performance metrics that fell short of market expectations. The company reported lower-than-anticipated new patient starts for its iLet automated insulin delivery system, prompting investor concerns regarding near-term adoption trends and revenue growth.
On this news, Beta Bionics stock fell roughly $11.85 or 37.04% to close at $20.14, on January 9, 2026.
To learn more about the Beta Bionics investigation, go to www.faruqilaw.com/BBNX or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/289233
Source: Faruqi & Faruqi LLP
Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Faruqi & Faruqi LLP or all companies in the Banking / Financial Services industry.
CHOW INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds ChowChow Cloud (CHOW) Investors of Securities Class Action Deadline on May 12, 2026
2026-03-20 9:45 AM EDT
TCPC INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds BlackRock TCP (TCPC) Investors of Securities Class Action Deadline on April 6, 2026
2026-03-20 9:44 AM EDT
INVESTOR ALERT: Faruqi & Faruqi, LLP Continues Investigation of Potential Securities Claims Against Bionics (BBNX)
2026-03-20 9:40 AM EDT
Aug 22, 2025
" The EDGAR Next deadline is no longer a future concern—it is an immediate compliance requirement. Companies that fail to complete enrollment risk losing filing access at a critical time. " The EDGAR Next deadline is only weeks away. On September 15, 2025, the SEC will switch to its new system, and companies that haven’t completed enrollment risk being unable to file. This article is a practical transition checklist—highlighting what’s changing, the steps to take now, and the last-minute...
Litigation and Regulation
Banking / Financial Services